Zytokine, metabolisches Syndrom und Ernährung

Zusammenfassung

Fettgewebe ist nicht nur ein passiver Energiespeicher, sondern ein aktives Gewebe, das zahlreiche Signalsubstanzen sezerniert. Hierzu zählen auch Zytokine wie IL-6, das als unabhängiger Risikofaktor für Diabetes beschrieben wurde. In der Zellkultur konnte tatsächlich auch ein kausaler Zusammenhang zwischen IL-6 und Insulinresistenz beobachtet werden. Die IL-6-Spiegel im Blut zeigten sich korreliert mit dem Anteil gesättigter Fettsäuren in der Nahrung. Der Effekt von gesättigten Fettsäuren auf die Insulinresistenz könnte daher teilweise durch IL-6 vermittelt sein. Interventionen mit unterschiedlichen Fettsäurezusammensetzungen der Nahrung sollten dann zu unterschiedlichen IL-6-Werten führen. Diese Studien sind aktuell allerdings noch uneinheitlich und schwierig zusammenfassend zu interpretieren. Auch verschlechterte eine niedrig dosierte IL-6-Gabe beim Menschen nicht die Insulinsensitivität und bei der Beurteilung von Studien, die den Zusammenhang zwischen IL-6 und Insulinsensitivität untersuchten, muss die Korrelation zwischen IL-6 und Übergewicht berücksichtigt werden. Weitere Studien sind daher notwendig zur Untersuchung des IL-6-Effektes beim Menschen und zur Beantwortung der Frage, in welchem Umfang Nahrungsfette Zytokine beeinflussen und inwieweit sich hierdurch ein zusätzlicher Effekt auf das individuelle Risiko erreichen ließe.

Abstract

Adipose tissue is not just a storage for energy but is actively secreting a large amount of signalling substances. Amongst them are cytokines like IL-6. IL-6 was shown to independently predict diabetes risk in humans and cell culture experiments could indeed describe a causal relationship between IL-6 and insulin sensitivity. IL-6 levels in human blood were described correlated to the intake of saturated fatty acids. IL-6 might therefore be a mediator of the impact of saturated fatty acids on insulin resistance. Intervention studies testing different fatty acid compositions are therefore supposed to yield different IL-6 levels. However, their results are so far unequal and difficult to interprete which does not allow to draw a final conlcusion. Additionally, low dose administration of IL-6 to humans failed to deteriorate insulin sensitivity and correlation analyses between IL-6 and insulin resistance must be interpreted with caution due to the tight relationship between IL-6 and obesity. Therefore, further studies are necessary to define IL-6 effects in humans and to address the question whether dietary fatty acids alter cytokines and whether this might further effect individual risk.

Ernährung - Fettgewebe - metabolisches Syndrom - Zytokine

nutrition - adipose tissue - metabolic syndrome - cytokines

Literatur

• 1 Greenberg A S, Obin M S. Obesity and the role of adipose tissue in inflammation and metabolism.  Am J Clin Nutr. 2006;  83 461S-465S
• 2 Linder K, Arner P. et al . Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women.  J Lipid Res. 2004;  45 148-154
• 3 Pradhan A D, Manson J E. et al . C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.  JAMA. 2001;  286 327-334
• 4 Spranger J, Kroke A. et al . Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.  Diabetes. 2003;  52 812-817
• 5 Engeli S, Feldpausch M. et al . Association between adiponectin and mediators of inflammation in obese women.  Diabetes. 2003;  52 942-947
• 6 Esposito K, Pontillo A. et al . Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.  JAMA. 2003;  289 1799-1804
• 7 Corpeleijn E, Saris W H. et al . Postprandial interleukin-6 release from skeletal muscle in men with impaired glucose tolerance can be reduced by weight loss.  J Clin Endocrinol Metab. 2005;  90 5819-5824
• 8 Fishman D, Faulds G. et al . The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.  J Clin Invest. 1998;  102 1369-1376
• 9 Kubaszek A, Pihlajamaki J. et al . The C-174G Promoter Polymorphism of the IL-6 Gene Affects Energy Expenditure and Insulin Sensitivity.  Diabetes. 2003;  52 558-561
• 10 Berthier M T, Paradis A M. et al . The interleukin 6 - 174G/C polymorphism is associated with indices of obesity in men.  J Hum Genet. 2003;  48 14-19
• 11 Klipstein-Grobusch K, Möhlig M. et al . Interleukin-6g - 174G > C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study.  Obesity (Silver Spring). 2006;  14 14-18
• 12 Bastard J P, Maachi M. et al . Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.  J Clin Endocrinol Metab. 2002;  87 2084-2089
• 13 Fernandez-Real J M, Vayreda M. et al . Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.  J Clin Endocrinol Metab. 2001;  86 1154-1159
• 14 Carey A L, Bruce C R. et al . Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.  Diabetologia. 2004;  47 1029-1037
• 15 Möhlig M, Spranger J. et al . The polycystic ovary syndrome per se is not associated with increased chronic inflammation.  Eur J Endocrinol. 2004;  150 525-532
• 16 Steensberg A, Fischer C P. et al . Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans.  J Physiol. 2003;  548 631-638
• 17 Weigert C, Brodbeck K. et al . Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-κB.  J Biol Chem. 2004;  279 23942-23952
• 18 Jove M, Planavila A. et al . Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor κB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells.  Endocrinology. 2005;  146 3087-3095
• 19 Fernandez-Real J M, Broch M. et al . Insulin resistance, inflammation, and serum fatty acid composition.  Diabetes Care. 2003;  26 1362-1368
• 20 Itani S I, Ruderman N B. et al . Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-alpha.  Diabetes. 2002;  51 2005-2011
• 21 Möhlig M, Freudenberg M. et al . Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men.  J Clin Endocrinol Metab. 2006;  91 964-967
• 22 Esposito K, Marfella R. et al . Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial.  JAMA. 2004;  292 1440-1446
• 23 Michalsen A, Lehmann N. et al . Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease.  Eur J Clin Nutr. 2006;  60 478-485
• 24 Hu F B, Stampfer M J. et al . Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women.  Am J Clin Nutr. 1999;  69 890-897
• 25 Bemelmans W J, Lefrandt J D. et al . Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis.  Eur J Clin Nutr. 2004;  58 1083-1089
• 26 Rallidis L S, Paschos G. et al . Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients.  Atherosclerosis. 2003;  167 237-242
• 27 Tuomilehto J, Lindstrom J. et al . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.  N Engl J Med. 2001;  344 1343-1350
• 28 Senn J J, Klover P J. et al . Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.  J Biol Chem. 2003;  278 13740-13746
• 29 Weigert C, Hennige A M. et al . Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells.  J Biol Chem. 2006;  281 7060-7067